Developing and Validating Digital Affective Patient Experience/Outcome Measure (ETVa)

April 7, 2020 updated by: Maritta Poyhonen-Alho, Helsinki University Central Hospital
The aim of the research project is to develop and validate a new digital measure of affective patient experience in maternal care. In this validating study extensive collection of affective ratings of 195 emotion words is collected. Pregnant women at different gestational stages are asked to provide affective ratings of 195 emotion words in relation to the dimensions: pleasure, arousal, dominance. Based on these ratings population averages and properties of emotion words will be calculated. The measure will be developed in respect to the analysis of affective rating and supplementing data.

Study Overview

Detailed Description

As there is an increasing demand for and interest in measures that take patient's emotions into account, this research project aims to develop and validate a new digital measure of affective patient-reported experience/outcome in maternal care.

In this validating study extensive collection of affective ratings of 195 emotion words will be collected. Pregnant women (N=1000) at different gestational stages are asked to provide affective ratings of 195 emotion words in relation to the dimensions: pleasure, arousal, dominance. This is done by using a visual Likert scale (Self-Assessment Manikin). The pregnant women participating in the research are also asked to answer to various questionnaires to identify patterns of personality, behavior and the state of health and well-being. Based on the affective ratings population averages and properties of emotion words will be calculated. The measure will be developed in respect to the analysis of affective ratings and supplementing data.

The research provides insights on how affective ratings could be connected to clinical indicators and patient experience.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Uusimaa
      • Helsinki, Uusimaa, Finland, 00029
        • The Hospital District of Helsinki and Uusimaa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Pregnant women attending maternal care in the Hospital District of Helsinki and Uusimaa

Description

Inclusion Criteria:

  • ongoing pregnancy
  • attending maternal care in the Hospital District of Helsinki and Uusimaa
  • fluent in Finnish
  • access to mobile communication device

Exclusion Criteria: none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
ETvalid
Pregnant women attending maternal care services and having access to computational device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
three-dimensional affective ratings
Time Frame: 9 months
affective rating of 195 emotion words in relation to pleasure, arousal, dominance (Lang 1980)
9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anxiety
Time Frame: 9 months
Generalized Anxiety Disorder Scale (GAD-7) (Spitzer et al. 2006). Scale is from 0 to 21. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.
9 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
S5 personality traits (30 facets of the Five-Factor Model)
Time Frame: 9 months
Short Five S5, a 60-item questionnaire (Konstabel et al 2012), is used to measure personality traits, more specifically, the 30 facets of the Five-Factor Model, using comprehensive single items (CSI).
9 months
emotion regulation
Time Frame: 9 months
State and Trait meta-mood questionnaire (adapted from: Mayer & Stevens 1994; Salovey et al 1995)
9 months
health related quality of life
Time Frame: 9 months
PROMIS-10 (Cella et al 2007)
9 months
emotional stress reaction
Time Frame: 9 months
Emotional Stress Reaction Questionnaire (ESRQ) (Larsson&Wilde-Larsson 2010)
9 months
subjective well-being
Time Frame: 9 months
Subjective Well-Being Questionnaire (SWB) (Lee et al 2013)
9 months
patient experience in maternal care
Time Frame: 9 months
Pregnancy- and maternity-care patients' experiences questionnaire (PreMaPeq) (Sjetne et al 2015)
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2018

Primary Completion (Actual)

February 28, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

October 17, 2017

First Submitted That Met QC Criteria

November 6, 2017

First Posted (Actual)

November 9, 2017

Study Record Updates

Last Update Posted (Actual)

April 8, 2020

Last Update Submitted That Met QC Criteria

April 7, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2329/2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

3
Subscribe